Corthera, Inc.(formerly BAS Medical, Inc.) clinical trials
Acquired by Novartis, Feb 3, 2010 · source ↗
The registry lists 5 studies whose lead sponsor is Corthera, Inc.(formerly BAS Medical, Inc.). 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 7, 2014.
- 5studies on the registry
- 0open to participants now
Before and after it joined Novartis
- First submitted before Corthera, Inc.(formerly BAS Medical, Inc.) became part of Novartis
- 5
- First submitted after Corthera, Inc.(formerly BAS Medical, Inc.) became part of Novartis
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
What it is testing
The drugs Corthera, Inc.(formerly BAS Medical, Inc.)’s studies test, most studies first; none is open now — 2 drugs with a page of their own. Each count opens the studies in search.
Studies, none open
All 5 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
Over the years
- 107
- 08
- 09
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 026
By the year each study started; 4 started before 2007. 2026 so far in the lighter column.
Registry sponsor names on this page
- Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies5 studies
Something wrong with this grouping? Tell us on the Novartis page.
Studies
Recruiting first, then most recently updated. Showing 5 of 5. All Novartis studies →
- Recombinant Human Relaxin (rhRlx) in Pregnant Women Scheduled for Induction of LaborCompletedNCT00259103Phase 2
Sponsor listed in the registry: Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies · First submitted before Corthera, Inc.(formerly BAS Medical, Inc.) became part of Novartis
- Recombinant Human Relaxin for the Treatment of Decompensated CHFTerminatedNCT00406575Phase 2
Sponsor listed in the registry: Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies · First submitted before Corthera, Inc.(formerly BAS Medical, Inc.) became part of Novartis
- Efficacy and Safety of Relaxin for the Treatment of Acute Heart FailureCompletedNCT00520806Phase 2/3
Sponsor listed in the registry: Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies · First submitted before Corthera, Inc.(formerly BAS Medical, Inc.) became part of Novartis
- Evaluation of the Safety of Relaxin in PreeclampsiaSuspendedNCT00333307Phase 1
Sponsor listed in the registry: Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies · First submitted before Corthera, Inc.(formerly BAS Medical, Inc.) became part of Novartis
- A Pilot Study of Recombinant Human Relaxin (rhRlx) in Compensated Congestive Heart FailureCompletedNCT00259116Phase 2
Sponsor listed in the registry: Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies · First submitted before Corthera, Inc.(formerly BAS Medical, Inc.) became part of Novartis